SLC7A11 and neoplasm: Several studies had confirmed that when GULT or glutaminase inhibitors were used on tumor cells with high expression of SLC7A11, the mortality of tumor cells was significantly increased, and this effect was independent of the GSH-GPX4 axis (23–25).